Клувот

Клувот is a human coagulation factor XIII used to support blood clotting processes. This intravenous therapy is prescribed for patients with congenital factor XIII deficiency. Suitable for adults and children, it helps maintain normal blood clot stability.

Клувот is used to treat congenital factor XIII deficiency, a rare bleeding disorder. It works by replacing the missing or deficient factor XIII in the blood, helping to stabilize blood clots and prevent excessive bleeding. This therapy is essential for patients who lack sufficient natural factor XIII production.

When administered, Клувот helps restore normal clotting function in patients with factor XIII deficiency. Users may experience improved clot stability and reduced risk of spontaneous bleeding episodes. The effects are typically observed shortly after infusion as the factor integrates into the bloodstream.

Клувот should be handled with care to avoid contamination or improper administration. It is intended for intravenous use only and must be prepared and administered by a healthcare professional. Patients should report any signs of allergic reactions or unusual symptoms during or after infusion.

No specific drug interactions have been widely documented for Клувот. However, as with any intravenous therapy, caution is advised when combining with other medications that affect blood clotting. Patients should inform their healthcare provider about all medications they are taking before starting this treatment.